A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Parecoxib Impurity 22 | CAS 181696-73-1 - Request Quote

Picture of Parecoxib Impurity 22

Parecoxib Impurity 22

SZ CAT No:SZ-P047027
CAS No
181696-73-1
Mol.F.
C16H15NO2
Mol.Wt.
253.3
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Parecoxib Impurity 22 is chemically 4,5-Dihydro-5-methyl-3,4-diphenyl-5-isoxazolol. Parecoxib Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Parecoxib Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Parecoxib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 181696-73-1

Purchase 181696-73-1

Order 181696-73-1

Enquire 181696-73-1

price of 181696-73-1

181696-73-1 Supplier

181696-73-1 Manufacturer

181696-73-1 Exporter

buy high quality Parecoxib Impurity 22

Purchase Parecoxib Impurity 22

Parecoxib Impurity 22 suppliers

Parecoxib Impurity 22 manufacturers

Parecoxib Impurity 22 price

Order Parecoxib Impurity 22

Enquire Parecoxib Impurity 22

Parecoxib Impurity 22 cost

Parecoxib Impurity 22 Supplier

Parecoxib Impurity 22 Distributor

Parecoxib Impurity 22 for Method Validation

Parecoxib Reference Standard

Parecoxib Impurity 22 for ANDA Filing

Parecoxib Impurity 22 for Forced Degradation Studies

Parecoxib Impurity 22 Identification Standards

Parecoxib Impurity 22 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,